Skip to main content
. Author manuscript; available in PMC: 2019 Dec 26.
Published in final edited form as: Int J Cancer. 2019 May 13;145(5):1270–1279. doi: 10.1002/ijc.32371

Table 3.

Combined Risk Genotypes of the Four Validated SNPs and Risk of BC in the DRIVE Study

Genotype Univariate analysis
Multivariate analysis2
NControl/NCase OR (95% CI) P NControl/NCase OR (95% CI) P

NUG1
 0 854/877 ref. 852/877 ref.
 1 5268/5769 1.07 (0.96–1.18) 0.2139 5252/5769 1.07 (0.97–1.19) 0.1805
 2 10067/11776 1.14 (1.03–1.26) 0.0091 10024/11776 1.15 (1.04–1.27) 0.0057
 3 6734/8365 1.21 (1.10–1.34) 0.0002 6705/8365 1.22 (1.10–1.35) <0.0001
 4 1417/1962 1.35 (1.20–1.52) <0.0001 1412/1962 1.36 (1.21–1.53) <0.0001
Trend <0.0001 <0.0001
 0–2 16189/18422 ref. 16128/18422 ref.
 3–4 8151/10327 1.11 (1.07–1.15) <0.0001 8117/10327 1.12 (1.08–1.16) <0.0001

Abbreviations: SNPs: single nucleotide polymorphisms; BC: breast cancer; DRIVE: Discovery, Biology, and Risk of Inherited Variants in Breast Cancer; NUG: number of unfavorable genotypes; OR: odd ratio; CI: confidence interval.

1

Risk genotypes were rs1323697 GC+CC, rs1264308 CC, rs141308737 C-/-- and rs1469412 TT.

2

Multivariate logistic regression analyses were adjusted for age and PCs.